Stemline Therapeutics B.V.
3 products tracked · names used in filings: Stemline Therapeutics B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Orserdu elacestrant | Authorised | 2023-09-15 |
| 🇪🇺 | Nexpovio selinexor | Authorised | 2021-03-26 |
| 🇪🇺 | Elzonris tagraxofusp | Authorised | 2021-01-07 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.